First Bank & Trust lifted its stake in shares of Zoetis Inc. (NYSE:ZTS – Free Report) by 0.8% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 10,002 shares of the company’s stock after purchasing an additional 83 shares during the period. First Bank & Trust’s holdings in Zoetis were worth $1,954,000 as of its most recent filing with the SEC.
Several other large investors have also modified their holdings of ZTS. Sarasin & Partners LLP lifted its position in shares of Zoetis by 546.3% during the second quarter. Sarasin & Partners LLP now owns 2,253,590 shares of the company’s stock worth $390,682,000 after purchasing an additional 1,904,899 shares during the last quarter. Swedbank AB bought a new position in Zoetis in the first quarter worth about $210,815,000. International Assets Investment Management LLC lifted its holdings in Zoetis by 41,235.7% in the third quarter. International Assets Investment Management LLC now owns 939,974 shares of the company’s stock worth $183,652,000 after acquiring an additional 937,700 shares during the last quarter. Marshall Wace LLP lifted its holdings in Zoetis by 7,608.6% in the second quarter. Marshall Wace LLP now owns 835,684 shares of the company’s stock worth $144,874,000 after acquiring an additional 824,843 shares during the last quarter. Finally, Vanguard Group Inc. lifted its holdings in Zoetis by 1.0% in the first quarter. Vanguard Group Inc. now owns 40,749,571 shares of the company’s stock worth $6,895,235,000 after acquiring an additional 414,605 shares during the last quarter. Institutional investors own 92.80% of the company’s stock.
Zoetis Price Performance
Zoetis stock traded down $1.49 during mid-day trading on Friday, hitting $180.01. The company’s stock had a trading volume of 2,623,220 shares, compared to its average volume of 2,517,962. The company has a quick ratio of 2.09, a current ratio of 3.45 and a debt-to-equity ratio of 1.32. The stock has a market capitalization of $82.14 billion, a P/E ratio of 34.68, a P/E/G ratio of 2.94 and a beta of 0.89. Zoetis Inc. has a twelve month low of $144.80 and a twelve month high of $201.92. The stock’s fifty day moving average price is $189.10 and its two-hundred day moving average price is $177.71.
Zoetis Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 3rd. Investors of record on Thursday, October 31st will be paid a $0.432 dividend. This represents a $1.73 dividend on an annualized basis and a yield of 0.96%. The ex-dividend date is Thursday, October 31st. Zoetis’s dividend payout ratio is 33.14%.
Wall Street Analyst Weigh In
A number of equities analysts have issued reports on the stock. Piper Sandler raised their target price on shares of Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a report on Wednesday, August 14th. BTIG Research raised their target price on shares of Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a report on Monday, August 12th. Argus raised shares of Zoetis to a “strong-buy” rating in a report on Friday, August 9th. JPMorgan Chase & Co. raised their price target on shares of Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Finally, Stifel Nicolaus raised their price target on shares of Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a research note on Wednesday, September 18th. Ten research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus target price of $221.44.
Get Our Latest Stock Analysis on Zoetis
Zoetis Company Profile
Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.
Featured Articles
- Five stocks we like better than Zoetis
- Airline Stocks – Top Airline Stocks to Buy Now
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Trading Stocks: RSI and Why it’s Useful
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- Stock Dividend Cuts Happen Are You Ready?
- MarketBeat Week in Review – 10/21- 10/25
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS – Free Report).
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.